This is not only false, but dangerously false. We are in the process of discovering that certain classes of popularly-prescribed drugs (eg ACE inhibitors for blacks, certain chemotherapy drugs for Asians) are ineffective or even toxic for populations not represented in the relevant drug development research cohorts. It's not identity politics to note that pharmacokinetics can differ between individuals and populations. These differences do not explain all of the population-level morbidity and mortality differences between ethnicities, but they are significant when investigating differences between groups on the same course of treatment.